A groundbreaking clinical trial, led by Australian researchers, has demonstrated that statins can be safely administered to healthy individuals over the age of 70 to significantly reduce their risk of heart attacks and strokes. The study found a low incidence of serious side effects associated with the common cholesterol-lowering medication in this demographic.
While statins are already a standard prescription for individuals under 75 with specific risk factors like diabetes and high cholesterol, this trial marks the first of its kind to explore their preventative benefits in a broader, otherwise healthy, older population. The findings suggest a potential expansion of statin use for primary prevention of cardiovascular events in the elderly.
Statins Show Promise for Heart Attack and Stroke Prevention in Healthy Over-70s
4 stories · 4 sources
#melatonin #cognition #researchOther digests
- 2026-09-19 — Bilingualism Linked to Enhanced Brain Health and Cognitive Function
- 2026-09-18 — Scientists Identify Brain Cells That May Trigger Sleep
- 2026-09-17 — RFK Jr. Pledges Support to Anti-Vaccine Group Amid Measles Outbreak
- 2026-09-16 — Fiji Declares National Emergency Amidst HIV Epidemic Fueled by Drug Use
- 2026-09-15 — Air Pollution Linked to Increased Suicide Risk, New Research Indicates
- 2026-09-14 — Measles Outbreak Claims Third Life in Pennsylvania; Anti-Vaccine Conference Draws RFK Jr.
- 2026-09-13 — Pennsylvania Reports Third Measles Death; Unvaccinated Woman Succumbs to Complications
- 2026-09-12 — New Research Explores Resistance Training for Muscle Function and Hypertrophy
- 2026-09-11 — Bouncy Castle MRSA Outbreak Infects 48 Children in Ireland
- 2026-09-10 — Esther Rantzen Too Frail for Swiss Assisted Dying
- 2026-09-09 — Apple's Health App to Feature 'Health Age' and Readiness Scores
- 2026-09-08 — Toilet Flushes Disperse Pathogen Plumes, Study Warns
- 2026-09-07 — BBC Anchor Maryam Moshiri Discloses Incurable Blood Cancer Diagnosis
- 2026-09-06 — Alzheimer's Prevention Trial Begins; Pig Kidney Transplant Patient Progresses
- 2026-09-05 — Alzheimer's Prevention Trial Targets Asymptomatic Individuals
- 2026-09-04 — Novartis Heart Drug Pelacarsen Trial Fails, Disappointing Medical Community
- 2026-09-03 — Genetically Modified Pig Kidney Sustains Man for Nine Months
- 2026-09-02 — Researchers Explore Brain 'Knobs' for Cognitive Enhancement
- 2026-09-01 — CDC Reports, Then Deletes, Measles Deaths Amidst Scrutiny
- 2026-08-31 — North Carolina Teen Dies From Rare Brain-Eating Amoeba Infection
- 2026-08-30 — Statins Show Promise for Heart Attack and Stroke Prevention in Healthy Over-70s
- 2026-08-29 — Psilocybin May Enhance Present Moment Brain Activity, Study Suggests
- 2026-08-28 — Global Heart Attack Definition Updated for Improved Patient Care
- 2026-08-27 — Antidepressant Withdrawal Management Improving Among Doctors
- 2026-08-26 — FDA Approves Daraxonrasib, Groundbreaking Targeted Therapy for Pancreatic Cancer
- 2026-08-25 — FDA Approves First Wearable Device for Combined Ketone and Blood Sugar Monitoring
- 2026-08-24 — Experts Recommend Meat Probes Amidst Widespread Salmonella Concerns
- 2026-08-23 — Vitamin D Linked to Improved Cognition in Sleep-Disturbed, Mildly Impaired Individuals
- 2026-08-22 — Prestige Brands Recalls 40,000 Bottles of Clear Eyes Eye Drops for Sterility Concerns
- 2026-08-21 — Study Examines Cancer Mortality in US Pilots and Flight Attendants